Literature DB >> 8895843

Effect of nicotine on the level of extracellular amino acids in the hippocampus of rat.

E Toth1.   

Abstract

Using microdialysis, we compared intracerebral and subcutaneous administration of nicotine for the effect on the levels of extracellular amino acids in the hippocampus of anesthetized rats. Administration by microdialysis of 10 mM nicotine, resulting in a nicotine concentration of 0.134 mumol/g in the hippocampus, increased the extracellular levels of aspartic acid, glutamic acid, and serine by 26-60%. At 50 mM nicotine the increases in the levels of aspartic acid, glutamic acid, serine, glycine, and glutamine were between 76% and 141%. Subcutaneous administration of nicotine at a dose of 6 mumol/kg caused a 57% increase in the extracellular level of glutamic acid. After a dose of 12 mumol/kg that resulted in a nicotine level of 0.015 mumol/kg in the hippocampus, the extracellular level of glutamic acid was increased by 100%, and that of aspartic acid by 24%. Thus, higher cerebral nicotine levels were needed with intracerebral than with subcutaneous administration to obtain similar amino acid changes. Prior administration of mecamylamine or L-kynurenine prevented the subcutaneous nicotine-induced elevation of the extracellular levels of aspartic acid and glutamic acid. Our results indicate that receptor interactions modulate nicotine effects and that both nicotinic cholinergic and NMDA/glycine glutamatergic receptors participate in the action of nicotine in increasing extracellular amino acid levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895843     DOI: 10.1007/bf02532339

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid.

Authors:  E Toth; H Sershen; A Hashim; E S Vizi; A Lajtha
Journal:  Neurochem Res       Date:  1992-03       Impact factor: 3.996

2.  Effects of smoking on rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

3.  Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine.

Authors:  S N Mitchell
Journal:  Neuropharmacology       Date:  1993-10       Impact factor: 5.250

4.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5.

Authors:  R G Morris; E Anderson; G S Lynch; M Baudry
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

5.  Amelioration of negative symptoms in schizophrenia by glycine.

Authors:  D C Javitt; I Zylberman; S R Zukin; U Heresco-Levy; J P Lindenmayer
Journal:  Am J Psychiatry       Date:  1994-08       Impact factor: 18.112

6.  Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia.

Authors:  T Klockgether; L Turski
Journal:  Ann Neurol       Date:  1993-10       Impact factor: 10.422

7.  Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis.

Authors:  J C Mifsud; L Hernandez; B G Hoebel
Journal:  Brain Res       Date:  1989-01-30       Impact factor: 3.252

8.  Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum.

Authors:  M O Krebs; F Trovero; M Desban; C Gauchy; J Glowinski; M L Kemel
Journal:  J Neurosci       Date:  1991-05       Impact factor: 6.167

9.  Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals.

Authors:  J K Wang; H Andrews; V Thukral
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

Review 10.  Excitatory amino acids and synaptic transmission: the evidence for a physiological function.

Authors:  P M Headley; S Grillner
Journal:  Trends Pharmacol Sci       Date:  1990-05       Impact factor: 14.819

View more
  9 in total

1.  Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function.

Authors:  E Shearman; S Rossi; H Sershen; A Hashim; A Lajtha
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.

Authors:  F E Kempsill; J A Pratt
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  The Neuroprotective Effect of Curcumin Against Nicotine-Induced Neurotoxicity is Mediated by CREB-BDNF Signaling Pathway.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Sulail Fatima; Fahimeh Faraji; Shiva Mozaffari
Journal:  Neurochem Res       Date:  2017-06-12       Impact factor: 3.996

4.  Changes in the glutamate release and uptake of cerebellar cells in perinatally nicotine-exposed rat pups.

Authors:  D K Lim; H S Kim
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

5.  Pre-synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms.

Authors:  S Zappettini; M Grilli; A Salamone; E Fedele; M Marchi
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.

Authors:  Mei Huang; Anna R Felix; Dorothy G Flood; Chaya Bhuvaneswaran; Dana Hilt; Gerhard Koenig; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

7.  Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus.

Authors:  Elisa Mura; Stefania Zappettini; Stefania Preda; Fabrizio Biundo; Cristina Lanni; Massimo Grilli; Anna Cavallero; Guendalina Olivero; Alessia Salamone; Stefano Govoni; Mario Marchi
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

8.  Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus.

Authors:  Stefania Zappettini; Massimo Grilli; Guendalina Olivero; Elisa Mura; Stefania Preda; Stefano Govoni; Alessia Salamone; Mario Marchi
Journal:  Front Pharmacol       Date:  2012-07-27       Impact factor: 5.810

Review 9.  The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.

Authors:  Raka Jain; Kaushiki Mukherjee; Yatan Pal Singh Balhara
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.